{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:00:55Z","timestamp":1780459255577,"version":"3.54.1"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002930","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T17:24:10Z","timestamp":1571678650000},"page":"e1002930","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Desmopressin and the risk of hyponatremia: A population-based cohort study"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2082-2445","authenticated-orcid":true,"given":"Michael","family":"Fralick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2575-467X","authenticated-orcid":true,"given":"Sebastian","family":"Schneeweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5990-4026","authenticated-orcid":true,"given":"Christopher J. D.","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8496-7806","authenticated-orcid":true,"given":"Emily H.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8867-2666","authenticated-orcid":true,"given":"Aaron S.","family":"Kesselheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,10,21]]},"reference":[{"key":"pmed.1002930.ref001","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1001\/jama.2017.4316","article-title":"FDA Approval of Desmopressin for Nocturia","volume":"317","author":"M Fralick","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"pmed.1002930.ref002","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.juro.2014.03.095","article-title":"A systematic review of the efficacy and safety of desmopressin for nocturia in adults","volume":"192","author":"MH Ebell","year":"2014","journal-title":"J Urol"},{"issue":"8092","key":"pmed.1002930.ref003","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(78)92749-6","article-title":"Beneficial Effect of DDAVP on Bleeding Time Von Willebrand\u2019s Disease","volume":"312","author":"C Menon","year":"1978","journal-title":"Lancet"},{"issue":"3","key":"pmed.1002930.ref004","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1542\/peds.92.3.420","article-title":"Desmopressin acetate and nocturnal enuresis: how much do we know?","volume":"92","author":"ME Moffatt","year":"1993","journal-title":"Pediatrics"},{"key":"pmed.1002930.ref005","unstructured":"U.S. Food and Drug Administration. Desmopressin drug label. 2007 [cited 2018 Jul 1]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2007\/017922s038,018938s027,019955s013lbl.pdf."},{"issue":"3","key":"pmed.1002930.ref006","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/01.ju.0000136203.76320.f6","article-title":"Clinical experiences with desmopressin for long-term treatment of nocturia","volume":"172","author":"G Lose","year":"2004","journal-title":"J Urol"},{"issue":"5","key":"pmed.1002930.ref007","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7257\/1053-816X.2010.30.5.276","article-title":"Demystifying nocturia: identifying the cause and tailoring the treatmen","volume":"30","author":"P Laureanno","year":"2010","journal-title":"Urol Nurs"},{"issue":"1","key":"pmed.1002930.ref008","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1464-410X.2011.10175.x","article-title":"The evaluation and treatment of nocturia: A consensus statement","volume":"108","author":"JP Weiss","year":"2011","journal-title":"BJU Int"},{"issue":"2","key":"pmed.1002930.ref009","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/nau.10053","article-title":"The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"P Van Kerrebroeck","year":"2002","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"pmed.1002930.ref010","first-page":"1","article-title":"Nocturia: Evaluation and Current Management Strategies","volume":"20","author":"CG Kowalik","year":"2018","journal-title":"Rev Urol"},{"issue":"4","key":"pmed.1002930.ref011","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bju.14183","article-title":"Desmopressin for treating nocturia in men","volume":"122","author":"J Han","year":"2018","journal-title":"BJU Int"},{"issue":"11","key":"pmed.1002930.ref012","first-page":"796a","article-title":"Desmopressin Effective for Treating Nocturia in Adults","volume":"90","author":"D Slawson","year":"2014","journal-title":"Am Fam Physician"},{"issue":"3","key":"pmed.1002930.ref013","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7326\/M18-0567","article-title":"Fracture risk after initiation of use of canagliflozin: A cohort study","volume":"170","author":"M Fralick","year":"2019","journal-title":"Ann Intern Med"},{"issue":"8","key":"pmed.1002930.ref014","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/pds.1926","article-title":"A basic study design for expedited safety signal evaluation based on electronic healthcare data","volume":"19","author":"S Schneeweiss","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"pmed.1002930.ref015","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/jama.2016.19970","article-title":"Using design thinking to differentiate useful from misleading evidence in observational research","volume":"317","author":"SN Goodman","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"pmed.1002930.ref016","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/pds.4729","article-title":"Quantifying bias reduction with fixed-duration versus all-available covariate assessment periods","volume":"28","author":"JG Connolly","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"pmed.1002930.ref017","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamainternmed.2018.6112","article-title":"Assessment of Use of Combined Dextromethorphan and Quinidine in Patients with Dementia or Parkinson Disease after US Food and Drug Administration Approval for Pseudobulbar Affect","volume":"179","author":"M Fralick","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"6","key":"pmed.1002930.ref018","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0895-4356(03)00006-4","article-title":"Validity of hospital discharge International Classification of Diseases (ICD) codes for identifying patients with hyponatremia","volume":"56","author":"KLL Movig","year":"2003","journal-title":"J Clin Epidemiol"},{"issue":"25","key":"pmed.1002930.ref019","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"PC Austin","year":"2009","journal-title":"Stat Med"},{"issue":"3","key":"pmed.1002930.ref020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/cpt.329","article-title":"Transparency and reproducibility of observational cohort studies using large healthcare databases","volume":"99","author":"S Wang","year":"2016","journal-title":"Clin Pharm Ther"},{"issue":"1","key":"pmed.1002930.ref021","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamainternmed.2017.3919","article-title":"Use of health care databases to support supplemental indications of approved medications","volume":"178","author":"M Fralick","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"6","key":"pmed.1002930.ref022","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/art.40084","article-title":"Cardiovascular safety of tocilizumab versus tumor necrosis factor inhibitors in patients with rheumatoid arthritis\u2014a multi-database cohort study","volume":"69","author":"SC Kim","year":"2017","journal-title":"Arthritis Rheumatol"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T07:30:16Z","timestamp":1664695816000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002930"}},"subtitle":[],"editor":[{"given":"Sanjay","family":"Basu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,21]]},"references-count":22,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002930","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,21]]}}}